Liothyronine sodium, a synthetic form of the thyroid hormone T3, can produce modest weight loss in people being treated for hypothyroidism, but it has not been shown to reliably cause weight loss in people whose thyroid function is already normal. In one crossover trial of hypothyroid patients, those taking liothyronine lost roughly two kilograms more than when they were on the standard thyroid replacement drug. That sounds straightforward, but the broader picture is messier, and the gap between what liothyronine does in a clinical trial and what people hope it will do as a diet aid is wide enough to be genuinely dangerous.
How Liothyronine Affects Metabolism
Your thyroid gland produces two hormones: T4 (thyroxine) and a smaller amount of T3 (triiodothyronine). T3 is the more biologically active of the two. Most thyroid hormone replacement prescriptions use levothyroxine (synthetic T4), which the body then converts to T3 as needed. Liothyronine sodium skips that conversion step and delivers T3 directly. Because T3 drives the metabolic rate of nearly every cell in the body, it seems logical that more T3 would mean a faster metabolism and therefore more weight loss. That logic is part of the reason liothyronine has been used, and misused, in weight-loss attempts for decades.
The reality is more complicated. When you give exogenous T3 to someone with a healthy thyroid, the body’s feedback system detects the extra hormone and dials down its own production. The net effect on metabolic rate can be surprisingly small. In a study of healthy volunteers receiving a single dose of liothyronine, serum T3 levels spiked to more than four times normal within about two hours, yet researchers found no measurable increase in energy expenditure, heart rate, or blood pressure compared to placebo.1PubMed Central. Acute Effects of Liothyronine Administration on Cardiovascular System and Energy Metabolism in Healthy Volunteers A one-time dose is not the same as chronic use, but the finding illustrates that simply flooding the body with T3 does not automatically translate into calorie burning.
What the Evidence Shows in Hypothyroid Patients
For people who are already taking thyroid hormone replacement because their own thyroid is underactive, the question is whether switching to liothyronine (or adding it to levothyroxine) helps with the stubborn weight gain that often accompanies hypothyroidism. The evidence here is mixed, and the details matter.
The most-cited positive result comes from a randomized, double-blind crossover trial comparing liothyronine monotherapy to levothyroxine monotherapy in hypothyroid patients. When participants were on liothyronine, their average body weight was about 68.5 kilograms compared to roughly 70.6 kilograms on levothyroxine, a difference of around two kilograms. Liothyronine also lowered total cholesterol by about 11 percent and LDL cholesterol by about 13 percent.2PubMed Central. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine Two kilograms is real, but it is modest, especially given that this was a controlled study in which doses were carefully managed by endocrinologists.
Other trials paint a less encouraging picture. A randomized controlled trial comparing combined levothyroxine-plus-liothyronine therapy to levothyroxine alone in patients with primary hypothyroidism found no change in body weight or serum lipid levels.3PubMed. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial A separate study of hypothyroid patients switched from levothyroxine monotherapy to combination therapy likewise found no change in body weight, though patients did report substantially improved quality of life, and the quality-of-life improvement could not be explained by any weight loss.4PubMed Central. Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss? That last point is worth lingering on: some patients feel noticeably better on liothyronine-containing regimens even when the scale does not budge. The subjective sense that something metabolic has shifted may be real, just not reflected in weight.
Why It Does Not Work as a Diet Drug for People With Normal Thyroids
If you have a functioning thyroid and you take liothyronine hoping to lose fat, you are essentially inducing a state of mild or overt hyperthyroidism. The body does not passively accept extra T3. Your hypothalamus and pituitary gland suppress TSH, which in turn reduces your thyroid’s own output of T4 and T3. At moderate doses, this compensatory mechanism can nearly cancel out the extra hormone. At higher doses you overwhelm the feedback loop, but then you are dealing with the consequences of true hyperthyroidism: muscle wasting, bone loss, heart rhythm disturbances, and anxiety.
A review of the clinical literature on thyroid hormone and obesity concluded plainly that there is no consistent evidence thyroid hormone treatment induces weight loss in obese people who are euthyroid, meaning their thyroid function is already normal.5Current Opinion in Endocrinology, Diabetes and Obesity. Thyroid hormone and obesity Any weight that does come off tends to be disproportionately lean tissue (muscle and organ mass) rather than fat, and it comes back quickly once the drug is stopped because the suppressed thyroid needs time to recover its normal output. That rebound period can leave someone temporarily more hypothyroid than they were at baseline.
The Peak-and-Crash Problem With Standard Tablets
One of the practical challenges with liothyronine is pharmacokinetic: the drug hits fast and wears off fast. After you swallow a standard tablet, circulating T3 levels spike sharply within a couple of hours and then decline over the next several hours. This spike-and-drop pattern is very different from the stable T3 levels a healthy thyroid maintains throughout the day.6PubMed Central. Sustained Release T3 Therapy: Animal Models and Translational Applications The clinical consequences are not just theoretical: patients often report feeling a surge of energy or warmth shortly after taking liothyronine, followed by a lull before the next dose. For someone using it for weight loss, this peak creates a transient window of supraphysiologic T3 exposure that carries cardiovascular risk without necessarily burning more calories across the full day.
Researchers have been working on sustained-release formulations to flatten that curve. A randomized trial of a combined levothyroxine-plus-sustained-release-liothyronine preparation found minimal variation in serum T3 concentration over 24 hours, with a time to peak concentration of about four and a half hours rather than the roughly two hours seen with conventional tablets.7PubMed Central. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained-release liothyronine; a randomized controlled clinical trial These slow-release approaches are still largely investigational, but they represent a recognition within endocrinology that the way liothyronine is currently delivered is part of its limitation.
A Long History of Thyroid Hormones as Diet Pills
The idea that thyroid hormones can make you thin is not new, and it has a genuinely dark track record. Beginning in the 1940s, several pharmaceutical companies marketed so-called “rainbow pills” that combined thyroid extract with amphetamines, barbiturates, laxatives, and diuretics in different-colored capsules. These cocktails were aggressively promoted to doctors and patients as weight-loss solutions. By the 1960s the pills had caused dozens of deaths before the FDA began pulling them from the market.8PubMed Central. The return of rainbow diet pills
One of the earliest controlled investigations into liothyronine specifically as a weight-loss aid dates to 1959. Researchers studied 57 obese patients on a strict 1,000-calorie diet plus a combination of amphetamine and a barbiturate. Half the patients also received 75 micrograms per day of liothyronine. Those getting the hormone continued to lose weight at roughly 0.39 kilograms per week over 16 weeks, while the group that stopped liothyronine plateaued.9JAMA. Results of Addition of Liothyronine to a Weight-Reducing Regimen That study is sometimes cited as proof the drug works, but its design is a product of its era. The participants were also taking amphetamines, the sample was small, and the dose of 75 micrograms per day is higher than what most endocrinologists would consider safe for extended use today. The broader lesson of the rainbow-pill era is that when you push thyroid hormone levels into the supraphysiologic range for the purpose of weight loss, the side effects eventually outweigh the benefit.
That pattern has persisted. A review of thyroid hormone misuse noted that some healthcare providers still prescribe thyroid hormone for unapproved indications like stimulating weight loss, sometimes at supraphysiologic doses. Whether the misuse is intentional or unintentional, exposure to exogenous thyroid hormone at above-replacement levels places individuals at risk for serious adverse effects.10Springer Link (Endocrine). Thyroid hormone misuse and abuse
Liothyronine in Bodybuilding and the Supplement Underground
Outside the clinic, liothyronine (often simply called “T3” in fitness circles) is widely used in bodybuilding and physique competition, typically during cutting phases when the goal is to shed fat while retaining as much muscle as possible. It is commonly stacked with anabolic steroids, and it is available from the same gray-market online pharmacies that supply those steroids. The doses used often exceed clinical ranges, and medical supervision is rare.
A published case report described a bodybuilder who presented to a hospital with tachycardia and features resembling sepsis. His T3 levels were markedly elevated, and after considerable diagnostic workup, he admitted to using supplementary testosterone and T3 as part of his regimen. The case highlighted how poorly understood and poorly recognized endocrine supplementation by bodybuilders can be among clinicians who are not looking for it.11PubMed Central. Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsis This is not a population that shows up in clinical trials, and the risks they face from unsupervised T3 use, including atrial fibrillation, bone density loss, and severe muscle catabolism, are real but difficult to quantify because the practice is underground.
Genetics and Why Some People Respond Differently
One emerging area of research may explain why some hypothyroid patients feel genuinely better (and sometimes lose weight) on liothyronine while others notice no difference at all. It comes down to a genetic variation in an enzyme called type 2 deiodinase, which converts T4 to T3 inside cells. A common polymorphism in the gene for this enzyme (known as Thr92Ala in the DIO2 gene) appears to impair that conversion, at least in certain tissues including the brain. Carriers of this variant show clinical improvement when liothyronine is added to their levothyroxine therapy.12PubMed Central. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain
This polymorphism is surprisingly common. Estimates vary by ethnicity, but roughly 12 to 36 percent of people carry at least one copy. For these individuals, standard levothyroxine therapy may leave their tissues relatively T3-deprived even when blood tests look normal. Adding liothyronine could correct a genuine intracellular deficit rather than simply flooding the body with excess hormone. Whether that correction translates into weight loss specifically, or instead into the improved energy and wellbeing that indirectly supports weight management, is still not clear. But this is the strongest biological rationale for why liothyronine might help some people more than others, and it suggests the future of T3 therapy may involve genetic screening rather than one-size-fits-all prescribing.
THRβ-Selective Drugs and the Search for a Safer Alternative
If the metabolic benefits of thyroid hormone could be separated from its cardiovascular and bone-related harms, you would have a genuinely useful drug for obesity and related conditions. That is exactly what a new class of compounds aims to do. Thyroid hormone works through two receptor subtypes. The alpha receptor (TRα) is the main mediator of thyroid hormone’s effects on the heart, while the beta receptor (TRβ) controls effects on cholesterol and fat metabolism. Activating TRβ selectively does not trigger the cardiac side effects, bone loss, or skeletal muscle breakdown that come with stimulating TRα.13PLOS One. KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression
Liothyronine itself is not selective. It binds TRα and TRβ with roughly equal affinity, which is why high doses come with heart risks. But newer compounds are being designed specifically for TRβ. One such molecule, ZTA-261, binds TRβ with about 100-fold greater affinity than it binds TRα, a far greater selectivity gap than natural T3.14Communications Medicine. Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261 The FDA’s approval in 2024 of resmetirom, a TRβ-selective agonist, for a liver condition related to metabolic dysfunction was the first such drug to reach the market, and it validated the broader concept. None of these compounds are currently approved specifically for weight loss, but they represent the direction the field is moving: harnessing the metabolic power of thyroid signaling while leaving the heart and skeleton alone.
What Happens When You Stop Taking It
Anyone considering liothyronine for weight management needs to understand what happens on the other side. When you take exogenous T3, your pituitary stops producing as much TSH, and your own thyroid gland becomes somewhat dormant. Stop the T3 abruptly and there is a gap before the feedback loop resets and your thyroid resumes adequate hormone production. During that gap, you may experience the hallmarks of hypothyroidism: fatigue, cold sensitivity, constipation, and weight gain. The weight that was lost often returns during this recovery period, sometimes with interest.
This rebound effect is one of the reasons liothyronine use for weight loss tends to become a cycle. People take it, lose some weight, stop, regain, and feel compelled to start again. In the bodybuilding community, this is sometimes managed with a gradual taper, but even a slow taper does not fully prevent the temporary suppression of the thyroid axis. The clinical trial that found a two-kilogram difference between liothyronine and levothyroxine was conducted in patients who were going to remain on thyroid hormone replacement regardless, so the cessation problem did not apply.15PubMed Central. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine For someone who does not need thyroid replacement, the on-off cycle introduces a risk that the temporary weight loss never justified.
Practical Takeaways If You Are Considering Liothyronine
If you have hypothyroidism and your weight has been resistant to change despite adequate levothyroxine dosing, the conversation with your endocrinologist about adding or switching to liothyronine is reasonable. The evidence for a small weight-loss benefit exists, and the improvement in quality of life seen in some studies could matter more to your daily experience than the number on the scale. Asking about the DIO2 polymorphism (a simple genetic test) could help predict whether you are likely to benefit.
If your thyroid function is normal and you are thinking about liothyronine purely as a weight-loss tool, the evidence does not support that use. The short-term metabolic boost is modest, the weight typically returns when you stop, and the risks, including heart rhythm abnormalities and bone thinning, are real and dose-dependent. Online forums and fitness influencers present T3 as a reliable fat burner, but those accounts are shaped by survivorship bias: you hear from the people who felt great, not from the ones who developed atrial fibrillation or spent months recovering from thyroid suppression. No major medical guideline recommends thyroid hormone for weight loss in euthyroid individuals, and the history of that practice, stretching back to the rainbow pills of the 1940s, is a cautionary one.